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Introduction
Skeletal muscle exhibits a tremendous capacity for regeneration 
in response to muscle injury induced by disease, trauma, or in-
tensive exercise. The process of muscle regeneration involves 
two distinct phases: a degenerative phase, in which infl  amma-
tory cells infiltrate the site of injury and play a critical role 
in the phagocytosis of necrotic myofi  bers, and a regenerative 
phase, in which muscle stem cells are activated, proliferate, dif-
ferentiate, and fuse to form new myofi  bers (Hawke and Garry, 
2001; Chen and Goldhammer, 2003; Charge and Rudnicki, 
2004; for review see Tidball, 2005). Crushed muscle fi  bers pro-
duce mitogenic factors, and, in addition, activated macrophages 
also secrete various cytokines and growth factors that are 
important for the activation and proliferation of satellite cells. 
Normally, the regenerated muscle is functionally identical to 
uninjured muscle, but if the regeneration process is compro-
mised, muscle tissue is replaced by scar tissue. Defects in the 
immune response (Lescaudron et al., 1999; Warren et al., 2005), 
altered production or signaling by growth factors (Floss et al., 
1997; McCroskery et al., 2003; Cornelison et al., 2004), or 
disruption of molecules that regulate cellular proliferation 
(Megeney et al., 1996; Garry et al., 2000; Hawke et al., 2003) 
result in impaired muscle regeneration.
Satellite cells (the skeletal muscle stem cells) are primarily 
responsible for regeneration (Hawke and Garry, 2001; Chen 
and Goldhammer, 2003; Charge and Rudnicki, 2004). Although 
normally quiescent, satellite cells are activated upon muscle 
damage and reenter the cell cycle, providing a pool of prolifer-
ating myoblasts that differentiate and fuse to form new myo-
fi  bers, leading to the complete regeneration of damaged muscles. 
Quiescent satellite cells do not express the myogenic basic 
helix-loop-helix (bHLH) factor MyoD (Cornelison and Wold, 
1997) but are positive for Pax7 (Seale et al., 2000) and CD34 
(Beauchamp et al., 2000). Upon activation by damage, satel-
lite cells proliferate and rapidly up-regulate the expression of 
myogenic factors MyoD and Myf5, whereas myogenin and 
MRF4 are up-regulated later during differentiation (Charge and 
Rudnicki, 2004). Several pathways, including hepatocyte growth 
factor (Tatsumi et al., 1998; Miller et al., 2000), myostatin 
(McCroskery et al., 2003), Notch (Conboy and Rando 2002), 
and p38α/β MAPK (Jones et al., 2005), regulate the transition 
of satellite cells from quiescence to an activated state. In addi-
tion, various cytokines and growth factors such as interleukin-4, 
transforming growth factor-β, and insulin-like growth factor 
(Allen and Boxhorn, 1989; Horsley et al., 2003; Li et al., 2004) 
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regulate proliferation and differentiation of myogenic precursor 
cells. Among the various pathways that regulate distinct steps of 
satellite cell activation, Notch signaling regulates not only the 
transition of satellite cells from quiescence to actively prolifer-
ating myoblasts but also plays a role in subsequent myogenic 
differentiation (Kopan et al., 1994; Conlon et al., 1995; Nofziger 
et al., 1999; Conboy and Rando 2002; Conboy et al., 2003).
The Notch signaling pathway plays an important role in 
cellular proliferation, differentiation, and apoptosis (Artavanis-
Tsakonas and Lake, 1999; Kadesch, 2004; Lai, 2004). Notch 
signaling is triggered by the interaction between Notch ligands 
and receptors. This interaction results in the proteolytic cleavage 
of Notch, which allows the release and translocation of Notch 
intracellular domain (NICD) into the nucleus, where it inter-
acts with the DNA-bound transcription factor CBF-1/RBPJk 
(recombination signal sequence–binding protein for Jκ). This 
association results in the recruitment of coactivators and the acti-
vation of downstream target genes Hes1, Hes5, Hey1, Hey2, and 
HeyL (Jarriault et al., 1995; Ohtsuka et al., 1999; Iso et al., 2003), 
which are members of the bHLH family of transcription factors. 
Because Notch signaling regulates different biological processes, 
it is not surprising that the pathway is tightly regulated at dif-
ferent levels, including expression of the ligands, trans  location 
of Notch into the nucleus, and regulation of NICD activity in 
the nucleus (Artavanis-Tsakonas and Lake, 1999; Kadesch, 2004; 
Lai, 2004).
Stra13/DEC1/SHARP-2 is a bHLH transcription factor 
that is expressed in a number of cell types during mouse embryo-
genesis (Boudjelal et al., 1997). Similar to Hes and Hey proteins, 
Stra13 contains an orange (O) domain, which is characteristi-
cally seen in all members of the bHLH-O transcriptional repressor 
subfamily (Davis and Turner, 2001). However, Stra13 differs 
from the Hes and Hey families in having distinct DNA-binding 
properties as well as transcriptional repression mechanisms 
(Boudjelal et al., 1997; Sun and Taneja, 2000). Stra13 expression 
is inducible by several stimuli in different cell types, and gain of 
function in cultured cells has demonstrated its role in the regula-
tion of cellular differentiation, cell cycle arrest, stress response, 
and apoptosis. For instance, the overexpression of Stra13 in 
many cell types causes cell cycle arrest (Sun and Taneja, 2000; 
Figure 1.  Normal skeletal muscle development in Stra13
−/− 
mice. (A) RNA from adult mouse tissues analyzed by Northern 
blotting revealed Stra13 expression in skeletal muscle. 36B4 
was used as an internal control. (B) E13.5 sagittal sections 
through the developing tongue of WT (+/+) and Stra13
−/− 
(−/−) embryos stained with anti-myogenin antibody revealed 
comparable expression, indicating normal muscle development. 
(C) HE staining of tibialis anterior muscles from WT (+/+) 
and Stra13
−/− (−/−) mice showed normal histology of 
Stra13
−/− muscle. (D) Measurement of the cross section area 
(CSA) of quadriceps did not reveal any overt difference in 
myoﬁ  ber size between WT and Stra13
−/− mice (n = 4). The 
cross section area of at least 1000 individual muscle 
ﬁ  bers was analyzed, and the mean areas were compared. 
(E) Tibialis anterior muscle from WT (+/+) and Stra13
−/− 
(−/−) mice (n = 3) stained with anti-Pax7 antibody indicated 
a comparable number of satellite cells (left). Arrows indicate 
satellite cells expressing Pax7. Quantiﬁ  cation of Pax7
+ cells 
per 100 myonuclei is shown on the right. At least 1,000 nuclei 
were counted for each animal, and the data presented are a 
mean of three animals. Data are means ± SEM (error bars). 
t, tongue. Bars, 100 μm.STRA13 ANTAGONIZES NOTCH SIGNALING • SUN ET AL. 649
Beadling et al., 2001; Li et al., 2002; Seimiya et al., 2002) and 
promotes neurogenic and chondrogenic differentiation (Boudjelal 
et al., 1997; Shen et al., 2002) but inhibits adipogenesis (Yun 
et al., 2002). We have previously shown that Stra13-null mice 
exhibit defects in T cell activation, which leads to the develop-
ment of a lupus-like autoimmune disorder (H. Sun et al., 2001) 
as well as defects in radiation-induced apoptosis (Thin et al., 
2007). However, the role of Stra13 in the development or func-
tion of other cell types has not been determined in vivo.
Because Stra13 is expressed in skeletal muscle (Boudjelal 
et al., 1997), in this study, we investigated its function in myo-
genesis and muscle regeneration in vivo. We found that although 
Stra13 is expressed in embryonic and adult muscles, it is dis-
pensable for skeletal muscle development. However, analysis 
of Stra13
−/− muscle upon injury revealed a striking defect in 
muscle regeneration characterized by degenerated myotubes, 
increased mononuclear cells, and fi  brosis. Interestingly, Notch 
signaling is elevated in Stra13
−/− primary myoblasts as well as 
in regenerating muscle. Strikingly, blocking Notch signaling 
ex vivo in Stra13
−/− myoblasts reduces cellular proliferation 
and enhances myogenic differentiation. Moreover, the inhibition 
of Notch signaling at late stages subsequent to satellite cell acti-
vation in vivo results in improved regeneration with a concomi-
tant reduction in cellular proliferation in Stra13
−/− mice. We 
demonstrate that Stra13 antagonizes the Notch-imposed inhibi-
tion of myogenic differentiation and inhibits Notch activity in 
vitro by interaction with the intracellular domain of Notch1, 
  resulting in its reduced association with CBF-1. We conclude 
that Stra13 plays an important role in the regulation of postnatal 
myogenesis by antagonizing Notch signaling.
Results
We have previously demonstrated that Stra13 is expressed in 
skeletal muscle during embryonic development (Boudjelal 
et al., 1997), and Northern blot analysis of various adult tissues 
further confi  rmed that Stra13 was expressed in differentiated 
adult muscles (Fig. 1 A). To evaluate myogenic differentiation 
in Stra13
−/− mutants, embryonic day (E) 13.5 embryo sections 
were stained with myogenin (Fig. 1 B) or myosin heavy chain 
(MHC) antibodies (not depicted), which did not reveal any 
  substantial difference between wild-type (WT) and Stra13
−/− 
embryos. Moreover, histological analysis of adult muscle sections 
from WT and Stra13
−/− mice did not reveal any overt differ-
ences in fi  ber morphology (Fig. 1 C) and fi  ber size (Fig. 1 D). 
The number of Pax7
+ satellite cells in tissue sections (Fig. 1 E) 
was also similar in both genotypes, indicating that Stra13 is dis-
pensable for skeletal muscle development.
Impaired muscle regeneration upon injury 
in Stra13
−/− mice
We next investigated whether Stra13 plays a role in postnatal 
myogenesis by inducing muscle regeneration in Stra13
−/− mice. 
WT and Stra13
−/− muscle were subjected to freeze injury (Conboy 
and Rando, 2002) and analyzed histologically at days 2, 5, 10, 
and 16 after injury. 2 d after injury, cross sections of quadri-
ceps muscles showed substantial fi  ber damage and infi  ltration 
of immune cells in both WT and Stra13
−/− mice (Fig. 2 A), and 
no phenotypic differences were apparent. 5 d after injury, the 
damaged area exhibited a mixed population of cells, which 
included necrotic fi  bers, activated satellite cells, proliferating 
myoblasts, differentiating myocytes, and newly formed myo-
tubes (Hawke and Garry, 2001) in both WT and Stra13
−/− mice. 
By days 10 and 16 after injury, damage was no longer visible 
in WT muscle, and the regenerated muscle contained newly 
formed myofi  bers. In contrast, Stra13
−/− muscle exhibited a 
  regeneration defect characterized by degenerated myotubes and 
the presence of many mononuclear cells. Moreover, Masson’s 
trichrome staining revealed collagen deposition in the intersti-
tium of injured muscles in Stra13
−/− mice (Fig. 2 B). These 
results showed that upon muscle injury, Stra13
−/− muscle 
exhibited impaired regeneration and enhanced fi  brosis.
Enhanced satellite cell activation in injured 
Stra13
−/− muscle
Because satellite cell activation is crucial for effi  cient regenera-
tion, we examined whether satellite cell activation is altered in 
Figure 2.  Impaired muscle regeneration in Stra13
−/− mice. (A) Skeletal 
muscle regeneration was induced by freeze injury in WT and Stra13
−/− 
mice, and muscle was collected on days 2 (D2), 5, 10, and 16 after injury. 
A clear boundary between the injured and uninjured tissue is visible. At 
days 10 and 16 after injury, myonecrosis and mononuclear cells are 
apparent in Stra13
−/− muscle. (B) Masson’s trichrome staining revealed 
collagen deposition (blue staining) in Stra13
−/− (−/−) muscle at day 16 
after injury. Bars, 100 μm.JCB • VOLUME 177 • NUMBER 4 • 2007  650
Stra13
−/− muscle. MyoD, an early marker of satellite cell acti-
vation, and Ki67, a marker for proliferating cells, were used to 
analyze the presence of activated myogenic precursor cells. 
MyoD
+ cells were detected in the injured tissue in both WT and 
Stra13
−/− muscle 2 d after injury (Fig. 3 A). At day 5, MyoD
+ 
cells increased in both genotypes as a result of the expansion of 
activated satellite cells, although a higher number of MyoD
+ 
cells were seen in Stra13
−/− muscle. 10 d after injury, MyoD 
expression dropped dramatically with myofi  ber  maturation, 
which left few MyoD
+ cells in WT muscle. In contrast, a sub-
stantially higher number of MyoD
+ cells were apparent in the 
damaged area in Stra13
−/− muscle by immunostaining, and 
Western blot analysis confi  rmed increased MyoD levels in the 
mutant tissue (Fig. 3 B). Similar results were seen with Ki67 
antibody (Fig. 3 C). These results indicated a sustained satellite 
cell activation leading to an increased number of myogenic pre-
cursor cells in Stra13
−/− regenerating muscle. To examine the 
differentiation status in Stra13
−/− regenerating muscle, muscle 
sections were stained on day 5 after injury with an antibody 
against embryonic MHC (eMHC), which is expressed in newly 
formed myotubes. Consistent with the histological analysis 
(Fig. 2 A), eMHC was expressed in Stra13
−/− myotubes (Fig. 3 D), 
and Western blot analysis revealed increased MHC levels at 
day 5 after injury (Fig. 3 D), likely as a result of an increase in 
the total number of newly formed myotubes. These results sug-
gested that although the number of myogenic precursor cells is 
increased, myogenic differentiation during muscle regeneration 
was not affected in the absence of Stra13.
Increased proliferation and impaired 
differentiation of Stra13
−/− myoblasts
To examine whether defective regeneration in Stra13
−/− mu-
tants occurs as a result of a cell-autonomous defect in the prolif-
eration and differentiation of myogenic precursor cells, primary 
myoblasts were isolated from WT and Stra13
−/− mice and ana-
lyzed for their ability to proliferate and differentiate in vitro. 
In growth medium, 20% of WT myoblasts exhibited BrdU 
  in  corporation, whereas 33% of Stra13
−/− myoblasts were labeled 
(Fig. 4 A). When cultured in differentiation medium, myoblasts 
exit the cell cycle, differentiate, and fuse to form myotubes. 
Stra13 mRNA (Fig. 4 B) was expressed at low levels in prolif-
erating WT myoblasts and was up-regulated upon the induction 
of differentiation. After 4 d in differentiation medium, almost 
90% of WT cells were MHC
+, whereas 70% of Stra13
−/− cells 
turned on MHC expression, suggesting defective differentiation 
(Fig. 4, C and D). Calculation of the fusion index revealed that 
>80% of WT myocytes contained more than two myonuclei in 
contrast to 20% for mutant myocytes (Fig. 4 E). Thus, although 
satellite cells from Stra13
−/− mutants exhibit an increased 
proliferation capacity both in vivo and in vitro, their inability to 
undergo myogenic differentiation and fusion was apparent 
only in vitro.
Figure 3.  Enhanced satellite cell activation in 
Stra13
−/− regenerating muscle. (A) Sections of 
injured muscle from WT and Stra13
−/− mice 
were immunostained on days 2 (D2), 5, and 
10 after injury with an antibody against MyoD. 
(B) Protein extracts from WT and Stra13
−/− re-
generating muscle on days 2, 5, and 10 after 
injury were analyzed using anti-MyoD antibody. 
(C) Sections of injured muscle from WT and 
Stra13
−/− mice were immunostained on days 
2, 5, and 10 after injury with antibody against 
Ki67. (D) Muscle sections on day 5 after injury 
were stained with monoclonal antibody against 
eMHC (top), and protein extracts from WT 
and Stra13
−/− regenerating muscle on day 
5 after injury were analyzed using anti-MHC 
antibody (bottom). Bars, 100 μm.STRA13 ANTAGONIZES NOTCH SIGNALING • SUN ET AL. 651
To confi  rm that increased myoblast proliferation and 
defective differentiation is a direct effect of Stra13 disruption, 
Stra13
−/− myoblasts were infected with a retrovirus expressing 
Stra13 or, as a control, with the retroviral vector alone. Stra13- 
expressing cells exhibited decreased BrdU incorporation in 
growth medium (Fig. 5 A). In addition, exogenously expressed 
Stra13 partially rescued the fusion index in differentiation 
medium (Fig. 5 B), indicating that the differentiation-defective 
phenotype may be partly noncell autonomous.
Enhanced Notch signaling 
in Stra13
−/− mutants
Because Stra13
−/− myoblasts exhibit a phenotype reminiscent 
of constitutively active Notch signaling (Conboy and Rando, 
2002), we hypothesized that increased Notch activity may 
underlie the altered proliferation and differentiation capacity 
of Stra13
−/− cells. To test this hypothesis, we examined Notch 
activity in WT and Stra13
−/− myoblasts using a CBF-1 re-
porter. N1IC (intracellular domain of Notch1)-induced CBF-1 
reporter activity was twofold higher in Stra13
−/− myoblasts 
compared with WT myoblasts (Fig. 6 A), indicating that N1IC 
is more active in the absence of Stra13. Among the Notch tar-
get genes, Hey1 has been shown to be a regulator of myogenic 
differentiation (J. Sun et al., 2001). As predicted with increased 
Notch activity, Hey1 RNA was expressed at higher levels in both 
proliferating and differentiating Stra13
−/− myoblasts (Fig. 6 B). 
Moreover, unlike WT cells, in which Hey1 expression was 
down-regulated upon differentiation, Stra13
−/− cells retained 
high levels of Hey1 (Fig. 6, B and C) similar to undifferen-
tiated cells.
Figure 4.  Increased proliferation and impaired differentiation of Stra13
−/− primary myoblasts. (A) WT and Stra13
−/− cells cultured in growth medium 
were pulsed with BrdU and immunostained with anti-BrdU antibody (left). The percentage of BrdU-positive cells was signiﬁ  cantly higher in Stra13
−/− cells 
compared with WT cells (right; *, P < 0.05). At least 500 cells were counted for each experiment, and three independent primary myoblast isolates for 
each genotype were assayed. Data are means ± SEM (error bars). (B) WT primary myoblasts were cultured in differentiation medium and collected on days 
0, 1, and 3. Stra13 mRNA level was measured by quantitative PCR. The results were normalized with glyceraldehyde-3-phosphate dehydrogenase and are 
presented as the mean of triplicates. Data are means ± SD. The experiment was repeated with three independent myoblast isolates, which gave similar 
  results. (C) Primary myoblast cells were differentiated and stained with antibody against MHC. Stra13
−/− myoblasts exhibited impaired differentiation and 
myotube formation. (D) The percentage of differentiated cells was calculated by counting the number of MHC-stained myocytes/total number of nuclei, 
which revealed lower myogenic differentiation in Stra13
−/− cells. (E) Calculation of fusion indices as the percentage of cells containing more than or equal 
to two nuclei within a differentiated myotube revealed the impaired fusion capacity of Stra13
−/− cells. (D and E) Data are means ± SEM (n = 3).
Figure 5.  Reexpression of Stra13 in Stra13
−/− myoblasts rescues the pro-
liferation and differentiation defect. Stra13
−/− myoblasts were transduced 
with retrovirus expressing Stra13 (pBabe-Stra13) or with vector alone 
(pBabe). After selection, infected cells were either pulsed with BrdU and 
analyzed for cell proliferation (A) or changed to differentiation medium for 
4 d and analyzed for myotube formation by MHC staining (B). The fusion 
index was calculated as described in Materials and methods. Data are 
means ± SEM (error bars). *, P < 0.05.JCB • VOLUME 177 • NUMBER 4 • 2007  652
Because Notch signaling is essential for progenitor cell 
expansion during muscle regeneration (Conboy and Rando, 
2002), we also examined Notch activity in regenerating muscle 
using antibodies directed against the activated form of Notch1 
and its target Hey1. A higher level of activated Notch1 was seen 
in Stra13
−/− muscle by immunostaining of regenerating muscle 
(Fig. 6 D) as well as by Western blot analysis (Fig. 6 E). Consis-
tent with elevated Notch activity, increased Hey1 expression 
was also evident in regenerating Stra13
−/− muscle by immuno-
staining in myofi  bers and, to a lesser degree, in mononuclear 
cells (Fig. 6 F). Quantitative PCR analysis confi  rmed increased 
Hey1 expression in the mutant tissue (Fig. 6 G), although 
changes in Hey1 RNA levels were less dramatic than changes in 
protein levels likely because of the contribution by both myo-
fi  bers and mononuclear cells, which already express Hey1.
Inhibition of Notch signaling reduces 
proliferation, enhances differentiation, and 
improves regeneration in Stra13
−/− mice
To test whether enhanced Notch activity was causal to the in-
creased proliferation and reduced differentiation of Stra13
−/− 
myoblasts, we treated WT and Stra13
−/− cells with the soluble 
Notch ligand Jagged-Fc fusion protein, which has previously 
been shown to antagonize Notch activity (Conboy et al., 2003). 
After treatment with Jagged-Fc, the proliferation of both WT 
and Stra13
−/− myoblasts was reduced, as indicated by decreased 
BrdU incorporation (Fig. 7 A). Moreover, when induced to dif-
ferentiate in the presence of Jagged-Fc, myotube formation was 
increased in Stra13
−/− myoblasts (Fig. 7 B). The fusion index of 
Stra13
−/− cells in the presence of Jagged-Fc also increased con-
siderably from <20 to >30% compared with untreated cells 
(not depicted), which is comparable with the effect seen with the 
reexpression of Stra13 in the mutant myoblasts (Fig. 5). Similar 
results were obtained using the γ-secretase inhibitor L685,458 
(unpublished data).
To determine whether sustained Notch signaling is re-
sponsible for increased cellular proliferation and defective 
  regeneration in Stra13
−/− mice, we tested whether the inhibition 
of Notch signaling at late stages could improve the regeneration 
status of Stra13
−/− mice. Injection of Jagged-Fc fusion protein 
directly into muscle 48 h after injury has previously been shown 
to inhibit Notch signaling and muscle regeneration by inhibiting 
satellite cell activation (Conboy et al., 2003). To circumvent such 
effects of Jagged-Fc on satellite cell activation at early stages, 
we injected Jagged-Fc into the injured muscle of Stra13
−/− 
mice 7 d after injury. 3 d later, mice were killed, and mus-
cles were analyzed histologically for regeneration. Strikingly, 
the injection of Jagged-Fc fusion protein   resulted in improved 
Figure 6.  Increased Notch activity in Stra13
−/− myoblasts. (A) A CBF-1 reporter was transfected in WT and Stra13
−/− myoblasts in the absence or presence 
of N1IC. A higher level of Notch-induced reporter activity was detected in Stra13
−/− myoblasts. Data are means ± SEM (error bars; n = 3). *, P < 0.05. 
(B and C) Primary myoblasts from WT and Stra13
−/− mice were induced to differentiate. Hey1 mRNA levels (B) were analyzed at days 0 and 3 by quan-
titative PCR, and Hey1 protein levels (C) were detected by immunostaining with anti-Hey1 antibody. GM, growth medium; DM, differentiation medium. 
(D and E) Immunostaining with anti-Notch1 antibody recognizing the activated form of Notch1 (D), and Western blot analysis (E) of WT and Stra13
−/− 
muscle analyzed on day 5 after injury exhibited enhanced Notch activation in Stra13
−/− regenerating muscle (n = 2). (F and G) Immunohistochemical 
detection (F) and quantitative PCR analysis (G) of regenerating muscle 5 d after injury showed increased Hey1 protein and mRNA level in Stra13
−/− regener-
ating muscle (n = 2). (B, C, F, and G) Data indicate means ± SD. Bars, 100 μm.STRA13 ANTAGONIZES NOTCH SIGNALING • SUN ET AL. 653
regeneration as assessed histologically by reduced necrosis 
(Fig. 7 C). Analysis of degenerated myotubes within the total 
injured region indicated that necrosis was seen in only 8–10% 
of the injured tissue in the presence of the inhibitor. In con-
trast, the contralateral muscle, which was not injected with the 
soluble ligand, exhibited impaired regeneration, and 25–30% of 
the injured tissue contained degenerated myotubes and necro-
sis. All three mice responded similarly to the Notch inhibitor 
and exhibited virtually identical effects. The number of proliferat-
ing Ki67
+ cells was also reduced by 50% in Jagged-Fc–injected 
muscle relative to untreated controls (Fig. 7 D). Therefore, our 
in vitro and in vivo data demonstrate that inhibition of Notch 
signaling can partially reverse the mutant phenotype, indicating 
that sustained Notch signaling underlies, at least in part, the 
  impaired muscle regeneration of Stra13
−/− mutants.
Stra13 suppresses Notch signaling 
by interaction with NICD
Enhanced Notch activity in Stra13
−/− cells suggested that Stra13 
inhibits Notch signaling. To examine this possibility, a CBF-1 
reporter was transfected in 10T1/2 cells along with N1IC in the 
absence or presence of Stra13. The overexpression of Stra13 
  repressed N1IC-induced reporter activity in a dose-dependent 
manner (Fig. 8 A). Consistently, N1IC-induced activation of the 
Hes1 promoter (Takebayashi et al., 1994) was also inhibited 
by Stra13 (Fig. 8 B). We then examined whether Stra13 exerted 
a similar effect on the endogenous expression of Notch target 
genes. 10T1/2 cells were transfected with expression vectors for 
Stra13, N1IC, or both N1IC and Stra13 and were analyzed by 
Western blotting and quantitative PCR for the endogenous ex-
pression of Hes1 and Hey1. Although Stra13 expression alone 
had no considerable effect, both genes were up-regulated by 
N1IC (Fig. 8 C). However, the coexpression of Stra13 along 
with N1IC suppressed Notch-induced Hes1 (Fig. 8 C, left) and 
Hey1 expression (Fig. 8 C, right), indicating that Stra13 inhibits 
the transcriptional activity of N1IC. To directly test the possibility 
that Stra13 inhibits Notch signaling in myogenic cells, we 
  established stable C2C12 cell lines expressing N1IC, which is 
constitutively active. Consistent with previous studies (Kopan 
et al., 1994; Nofziger et al., 1999), unlike control C2C12 cells 
that effi  ciently differentiate into myotubes, N1IC-expressing 
cells failed to differentiate (Fig. 8 D). Interestingly, however, 
the retroviral expression of Stra13 in N1IC-expressing cells res-
cued 20% of myogenic differentiation as assessed by quanti-
fying the percentage of multinucleated myotubes within MHC
+ 
cells, indicating that Stra13 regulates myogenic differentiation 
through the inhibition of Notch signaling.
To examine the mechanism by which Stra13 inhibits 
Notch signaling, we tested whether Stra13 interacts with N1IC 
by coimmunoprecipitation assays. Myc-tagged N1IC was co-
transfected with Stra13 or with Flag-tagged CBF-1 in 293T 
cells. Lysates were immunoprecipitated with anti-Stra13 anti-
body or with anti-Flag antibody and subjected to SDS-PAGE. 
Western blot analysis with anti-myc antibody revealed that 
Stra13 interacts with N1IC (Fig. 9 A), and, as expected, an inter-
action between N1IC and CBF-1 was also seen. GST pull-down 
assays confi  rmed a direct interaction between Stra13 and the 
Notch1 intracellular domain (Fig. 9 B). Because Stra13 inter-
acts with N1IC, we considered the possibility that this inter-
action may reduce the association of N1IC with CBF-1. 
Therefore, we examined the interaction of CBF-1 and N1IC in the 
absence or presence of Stra13 by coimmunoprecipitation assays. 
Figure 7.  Modulation of Notch signaling attenuates the pro-
liferation and differentiation defect of Stra13
−/− cells and im-
proves muscle regeneration. (A) WT and Stra13
−/− myoblasts 
were cultured in growth medium in the absence and presence 
of Jagged-Fc. Cells were pulsed with BrdU and stained with 
anti-BrdU antibody. The percentage of BrdU-positive cells was 
signiﬁ  cantly lower in Jagged-Fc–treated Stra13
−/− cells com-
pared with untreated cells. Data are means ± SEM (error 
bars; n = 4). *, P < 0.05. (B) WT and Stra13
−/− myoblasts 
were cultured in the absence and presence of Jagged-Fc in 
differentiation medium for 4 d. Myogenic differentiation 
was visualized by MHC staining. Note that most nuclei are 
located within MHC
+ cells in the presence of Jagged-Fc. 
(C) Stra13
−/− mice were injured and, 7 d later, injected with 
Jagged-Fc or the control vehicle. 3 d after injection, muscle 
was analyzed histologically by HE staining. Using ImageJ, 
the area covered by necrotic ﬁ  bers within the total damaged 
area was analyzed for each animal. Mean areas were com-
pared and quantiﬁ  ed. Jagged-Fc–injected muscle shows re-
duced necrosis (arrows) compared with the control uninjected 
muscle (P < 0.05). (D) Control and Jagged-Fc–injected sec-
tions were stained with anti-Ki67 antibody. A reduction in 
Ki67
+ cells in the Jagged-Fc–injected muscles was seen by 
immunostaining. The results are representative of three inde-
pendent animals.JCB • VOLUME 177 • NUMBER 4 • 2007  654
Interestingly, the amount of CBF-1 that is associated with N1IC 
was reduced in the presence of Stra13 (Fig. 9 C). Thus, we 
  conclude that the interaction of Stra13 with N1IC reduces the 
association of N1IC with CBF-1, resulting in inhibition of the 
Notch-dependent activation of target genes. 
Discussion
Notch signaling plays a prominent role in the regeneration of 
skeletal muscle (Conboy and Rando, 2002), and insuffi  cient 
Notch activity in ageing satellite cells leads to reduced regener-
ative potential (Conboy et al., 2003). However, sustained Notch 
activity is incompatible with myogenic differentiation (Kopan 
et al., 1994; Nofziger et al., 1999; Conboy and Rando, 2002). 
Subsequent to satellite cell activation, Notch signaling is attenu-
ated during differentiation by up-regulation and asymmetric lo-
calization of its antagonist Numb (Conboy and Rando, 2002). 
Because alterations in Notch activity can have profound effects 
on the regenerative response, it is likely that Notch signaling is 
controlled at multiple steps. The results of this study reveal 
an unanticipated function for Stra13 as an inhibitor of Notch 
transcriptional activity. We demonstrate that Stra13 regulates 
myoblast proliferation and differentiation by modulating Notch 
signaling and is required for effi  cient muscle regeneration.
Several lines of evidence suggest that Stra13, like Numb, 
is critical for the attenuation of Notch signaling in satellite cells. 
First, Stra13
−/− primary myoblasts exhibit enhanced prolifera-
tion and defective differentiation, a phenotype that is remark-
ably similar to the expression of constitutively active Notch in 
myoblasts (Nofziger et al., 1999; Conboy and Rando, 2002). 
Second, Notch reporter activity and the expression of its down-
stream target Hey1 are increased in Stra13
−/− myoblasts. The 
increased Notch activity in proliferating Stra13
−/− myoblasts 
suggest that persistent Notch activity is not likely to be secondary 
to defective differentiation but rather causal to it. Note that 
Stra13 is expressed at low levels in proliferating satellite cells 
when Notch activity is high, and its expression is up-regulated 
during terminal differentiation concomitant with reduced Notch 
signaling. Third, treatment with the Notch antagonist Jagged-Fc 
resulted in reduced proliferation and enhanced myotube forma-
tion in Stra13
−/− myoblasts. Fourth, Notch-induced inhibition 
of myogenic differentiation in C2C12 cells can be partially over-
come by the forced expression of Stra13. Finally, Stra13 inter-
acts with NICD and inhibits its transcriptional activity.
Figure 8.  Stra13 inhibits Notch signaling. (A) 100 ng of 
a CBF-1 reporter construct was transfected in 10T1/2 cells 
along with 10 ng N1IC in the absence or presence of increasing 
amounts of Stra13 (10, 25, 50, and 100 ng). (B) 100 ng 
Hes-1 promoter was transfected with 10 ng N1IC in the ab-
sence or presence of 100 ng Stra13. Reporter assays were 
repeated at least three times, each with duplicates. Data are 
means ± SEM (error bars). (C) 10T1/2 cells were transfected 
with vector (pCS2), Stra13, N1IC, or both N1IC and Stra13. 
The expression of Stra13, N1IC, and Hes1 was detected by 
Western blotting (left). Hey1 mRNA level was analyzed by 
quantitative PCR (right). (D) Control C2C12 cells or stable cell 
lines expressing Notch (C2C12-N1IC) were stained for MHC 
4 d after culturing in differentiation medium. C2C12-N1IC 
cells were blocked in myogenic differentiation. C2C12-N1IC 
cells were transduced with an empty retroviral vector (Babe) 
or one expressing Stra13 and stained for MHC after 4 d in 
differentiation medium (left). The expression of Notch and 
Stra13 was detected in N1IC-vector and N1IC-Stra13 cell 
lines by Western blot analysis (right).STRA13 ANTAGONIZES NOTCH SIGNALING • SUN ET AL. 655
Consistent with these observations in primary myoblasts, 
increased levels of activated Notch and Hey1 are also evident 
in regenerating Stra13
−/− muscle. As predicted with elevated 
Notch signaling, the number of myogenic precursor cells is in-
creased, indicating elevated satellite cell activation and myo-
genic precursor cell expansion during regeneration in Stra13
−/− 
muscle. However, in contrast to the differentiation defect of 
Stra13
−/− myoblasts in vitro, myogenic differentiation is not 
perturbed in Stra13
−/− regenerating muscle. These observations 
suggest that in vivo, compensatory mechanisms allow myo-
genic differentiation to proceed despite elevated Notch activity. 
Several possibilities may account for this paradox. During re-
generation, both MyoD and activated Notch levels are elevated 
in the mutant tissue. It is possible that the increase in Notch ac-
tivity is insuffi  cient to completely block MyoD levels (Nofziger 
et al., 1999; Conboy and Rando, 2002), and, thus, despite ele-
vated Notch activity, myogenic differentiation in vivo proceeds 
normally. Moreover, elevated Notch1 and Hey1 are apparent in 
newly formed myofi  bers in the mutant tissue. Although the role 
of Notch signaling in the proliferation and differentiation of 
progenitor cells is well established, its potential function in dif-
ferentiated cells is unclear. Because Notch activity is high in the 
mutants in newly formed myofi  bers that have already differenti-
ated, it is possible that under these conditions, Notch is unable 
to inhibit MyoD levels and block the differentiation of  progenitor 
cells. However, sustained Notch activity in newly formed myo-
fi  bers may result in their degeneration, leading to defective 
  regeneration. In support of this possibility, the injection of 
Jagged-Fc into injured muscles of Stra13
−/− mice at day 7 results 
in improved histopathology, as seen by reduced necrosis and 
Ki67
+ cells, suggesting that deregulated Notch signaling in vivo 
is indeed one underlying basis of the defective regeneration of 
Stra13
−/− mice. 
An alternative possibility for the relatively normal differ-
entiation during regeneration could be through the altered pro-
duction of growth factors and cytokines by injured muscle and 
immune cells that regulate satellite cell activation, proliferation, 
and differentiation. For instance, we have previously demon-
strated the aberrant CD4
+ T cell activation (H. Sun et al., 2001) 
and reduced production of several cytokines, including inter-
leukin-4 in Stra13
−/− mice, which is required for effective 
  regeneration (Horsley et al., 2003). Activation of peritoneal 
macro  phages is also impaired in Stra13
−/− mice, resulting in 
the reduced production of cytokines interleukin-1β and TNF-α 
(unpublished data). Macrophages play a critical role in muscle 
regeneration not only in the clearance of necrotic debris but also 
at late stages in the fusion of myofi  bers, and TNF-α receptor 
mutants are impaired in their regenerative response (Warren 
et al., 2005). It is conceivable that the infl  ammatory reaction and 
expression of various cytokines after muscle injury may be 
altered in Stra13
−/− mice. The reduced production of inhibitory 
cytokines that normally block myogenesis may allow myotube 
formation in vivo but would obviously have no impact on the 
differentiation of cultured myoblasts in vitro. Therefore, it is 
likely that Stra13 regulates postnatal myogenesis through cross 
talk with distinct pathways, and the cumulative effects of 
muscle–cell intrinsic and extrinsic changes lead to diminished 
regenerative capacity in vivo.
Few inhibitors of Notch signaling have been identifi  ed, 
which include the cytoplasmic regulator Numb as well as the 
nuclear antagonists Msx2-interacting nuclear target protein 
(MINT), Hairless, and Nubbin (Kopan, 1999; Kadesch, 2004). 
Unlike Numb, which attenuates Notch signaling by interacting 
with NICD and regulating the endocytosis and ubiquitination of 
Notch, Stra13 represses Notch signaling in the nucleus by re-
ducing its interaction with CBF-1. Because Notch activity needs 
to be precisely regulated spatially and temporally during muscle 
regeneration, it is likely controlled at multiple steps. Whether 
Numb and Stra13 function at distinct temporal phases or, alter-
natively, function at the same time but at distinct locations to 
ensure the complete inhibition of Notch activity remains to be 
determined. The intracellular domain of Notch is constitutively 
active in the nucleus and bypasses ligand requirement. Because 
Stra13 antagonizes the activity of NICD both in vitro as well as 
functionally in myogenic C2C12 cells, our results suggest that 
Stra13 may directly repress Notch signaling independently of 
the effects on ligand expression. Nevertheless, we cannot ex-
clude the possibility that in vivo, Stra13 may regulate Notch 
Figure 9.  Stra13 physically interacts with Notch1 intercellular 
domain and prevents it from binding to CBF-1. (A) 293T 
cells were transfected with myc-tagged N1IC and Stra13 or 
Flag–CBF-1 as indicated. Lysates were immunoprecipitated 
with anti-Stra13 or anti-Flag (CBF-1) antibodies and analyzed 
by Western blotting with anti-myc (N1IC) antibody, which 
shows the interactions of Stra13 and N1IC (left) and N1IC 
with CBF-1 (right). (B) GST-Stra13 was tested for interaction 
with in vitro translated N1IC. GST was used as a control. 5% 
of input was run on the gel. (C) 293T cells were transfected 
with 2 μg Flag–CBF-1, and 0.2 and 0.7 μg of different 
amounts of myc-N1IC in the presence (2 μg) or absence of 
Stra13. Cell lysates were immunoprecipitated with anti-Flag 
(CBF-1) antibody and analyzed by Western blotting with anti-
myc (N1IC) antibody (top). The bottom panel shows Western 
blot analysis of CBF-1, N1IC, and Stra13 expression.JCB • VOLUME 177 • NUMBER 4 • 2007  656
signaling at additional levels, including the transcriptional regu-
lation of Delta, regulation of Numb expression or localization, 
or by dimerization with Hes or Hey proteins. It will be of in-
terest to precisely defi  ne these changes in order to fully understand 
the molecular mechanisms by which Stra13 regulates skeletal 
muscle regeneration.
Materials and methods
Regeneration studies
Stra13
−/− mice have been previously described (H. Sun et al., 2001). 3-mo-
old littermate WT and Stra13
−/− mice were injured by applying a metal 
probe precooled in dry ice for 10 s. At least two mice were analyzed per 
time point (2, 5, 10, and 16 d after injury) in each experiment, and regen-
eration studies were performed four times. All animal protocols followed 
  institutional guidelines. To inhibit Notch signaling, the quadriceps muscles 
were subjected to freeze injury. 7 d after injury, 15 μl (1.5 μg) Jagged-Fc 
fusion protein (R&D Systems) was injected into six sites of injured muscles. 
PBS (in 0.1% BSA) was injected in the contralateral injured muscle. 3 d after 
injection, muscles were collected and analyzed histologically.
Antibodies
Anti-Stra13 (Dec1) antibody was provided by B. Yan (University of Rhode 
Island, Kingston, RI). Anti-MyoD, anti-myogenin, and anti-Notch1 (mN1A 
and C-20) were obtained from Santa Cruz Biotechnology, Inc. Antibody 
against activated Notch1 (Val1744) was purchased from Cell Signaling, 
anti-Ki67 was purchased from Novocastra, and anti-Hey1 was obtained 
from Chemicon. Anti-BrdU, anti-MHC, and anti–β-actin were purchased 
from Sigma-Aldrich, anti-Hes1 was a gift from Y.N. Jan (University of Cali-
fornia, San Francisco, San Francisco, CA), anti-EF1α was purchased from 
Upstate Biotechnology, and anti-Pax7 and anti-eMHC were obtained from 
Developmental Studies Hybridoma Bank.
Histology, immunohistochemistry, and microscopy
Serial cross sections were collected along the length of muscle, and one in 
every six slides was stained with hematoxylin and eosin (HE). Sections from 
both genotypes with comparable damaged areas were used for histological 
and immunohistochemical analysis. Immunohistochemistry was performed 
as described previously (H. Sun et al., 2001). In brief, parafﬁ  n-embedded 
sections were incubated with primary antibody, and staining without pri-
mary antibody served as a negative control. After washes, slides were in-
cubated with biotinylated secondary antibodies and developed using 
V  E  C  T  A  S  T  A  I  N   Elite ABC kit (Vector Laboratories). Masson’s trichrome stain-
ing was performed using a kit from Diagnostic Biosystems. Phase-contrast 
microscopy was performed using a microscope (Eclipse TS100; Nikon) with 
plan Fluor 10× NA 0.3 and 20× NA 0.45 objectives (Nikon) at room tem-
perature, and images were captured using a camera (2.2.1 Spot RT Color; 
Diagnostic Instruments) and Spot software (version 3.5.9; Diagnostic Instru-
ments). All ﬁ  gures were prepared using Photoshop version 7.0 (Adobe).
Fiber size
Quadriceps muscles from four mice of each genotype were embedded in 
parafﬁ  n. Sections from the center of the muscle were stained with HE, and 
the cross section area of individual myoﬁ  bers was measured using ImageJ 
software (version 1.36b; National Institutes of Health).
Statistical analysis
For all analysis, at least three to four mice per time point or treatment 
were used. An unpaired t test was used for all statistical calculations, and 
P-values of <0.05 were considered to be statistically signiﬁ  cant.
Satellite cell number
Frozen sections of tibialis anterior muscle from 1-mo-old mice were stained 
with anti-Pax7 antibody and counterstained with hematoxylin. Both Pax7
+ 
nuclei and myonuclei were counted from several random ﬁ  elds for each 
animal, and the percentage of satellite cells was calculated as the number 
of Pax7
+ cells per 100 myonuclei. Myonuclei were identiﬁ  ed based on 
their location being closely associated with myoﬁ  bers, and interstitial nu-
clei were excluded from the counting.
Cell culture, transfection, and luciferase assays
C3H10T1/2 and 293T were maintained in DME containing 10% FBS. Tran-
sient transfections were performed using LipofectAMINE Plus (Invitrogen). 
Empty expression vectors were added to normalize the amount of DNA 
in each well. Luciferase assays were performed using the dual luciferase 
system (Promega). C2C12 cells were maintained in DME containing 20% 
FBS. To establish stable cell lines, C2C12 cells were transfected with a vec-
tor expressing N1IC. Cells were selected with G418, and several indepen-
dent colonies were tested for N1IC expression. For rescue experiments, 
two independent N1IC-expressing cell lines were transduced with a vector 
alone or retroviral vector expressing Stra13 (pBabe-Stra13) and selected 
with puromycin. After selection, the bulk population of infected cells was 
switched to differentiation medium (DME with 2% horse serum) for 4 d and 
immunostained with anti-MHC antibody.
Primary myoblasts, proliferation, and differentiation
Primary myoblasts were isolated as previously described (Rando and Blau, 
1994). In brief, hindlimb muscles were dissected from 3-wk-old mice and 
digested with collagenase. Single-cell suspensions were resuspended in 
growth medium (20% FBS in F-10 medium supplemented with 5 ng/ml 
basic FGF) and plated on collagen-coated cell culture dishes. After two to 
three passages, >95% of cells were myogenic, as seen by staining with 
Pax7, c-met, and desmin antibodies. All assays were performed with pri-
mary myoblasts within passages four to seven, and three to four indepen-
dent isolates were used for each assay. For differentiation assays, myoblasts 
were cultured in differentiation medium (DME with 5% horse serum) and 
harvested at the times indicated. The percentage of differentiated cells was 
calculated by counting the number of MHC-stained myocytes/total number 
of nuclei. The fusion index was calculated as the percentage of cells con-
taining more than two nuclei within MHC
+ cells. For proliferation assays, 
myoblasts in growth medium were incubated with 20 μM BrdU for 3.5 h 
and immunostained with an antibody against BrdU. For rescue experi-
ments, Stra13
−/− myoblasts were infected with pBabe or pBabe-Stra13. 
Infected cells were selected with 1 μg/ml puromycin for 2 d, expanded, 
and subjected to proliferation and differentiation assays. To inhibit Notch 
signaling, WT and Stra13
−/− myoblasts were cultured in the presence of 
1 μg/ml Jagged-Fc (R&D Systems) and subjected to proliferation and dif-
ferentiation assays.
Coimmunoprecipitation and GST pull-down assays
Coimmunoprecipitation and GST pull-down assays were performed as de-
scribed previously (Sun and Taneja, 2000). For coimmunoprecipitation as-
says with transfected plasmids, 400 μg of cell lysate was incubated with 
2 μg of antibodies followed by the addition of protein A/G plus agarose 
beads. Proteins were eluted and subjected to SDS-PAGE. Western blotting 
was performed with anti-myc, anti-Flag, or anti-Stra13 antibodies. For GST pull-
down assays, N1IC was translated in vitro and labeled with [
35S]methionine 
using the rabbit reticulocyte in vitro transcription-translation system (TNT; 
Promega). 
35S-labeled N1IC was incubated with puriﬁ  ed GST-Stra13 (Sun 
and Taneja, 2000) or GST in binding buffer. Samples were run on SDS 
gels and detected by autoradiography.
Quantitative real-time PCR
Total RNA was extracted using TRIzol (Invitrogen) or with an RNeasy kit 
(QIAGEN) and treated with Rnase-free DNaseI (TURBO DNA-free kit; 
  Ambion). Quantitative real-time PCR was performed using the Quantitect SYBR 
green PCR kit (QIAGEN) with 10 ng cDNA as a template. Each sample was 
ampliﬁ  ed in triplicate in a thermocycler (ABI Prism 7900HT; Applied Bio-
systems). PCR cycling conditions were as follows: 95°C for 15 min and 40 
cycles of 95°C for 15 s, 55°C for 30 s, and 72°C for 30 s. Amplicon size 
was conﬁ  rmed by agarose gel electrophoresis. Quantitative PCR standard 
curves were constructed by using serial dilutions of total RNA isolated from 
day 5 regenerating muscle. All data were normalized to glyceraldehyde-
3-phosphate dehydrogenase. The primer pairs used were as follows: Hey1 
(C  T  T  G  A  G  T  T  C  G  G  C  T  C  T  G  T  G  T  T  C  C   and G  A  T  G  C  C  T  C  T  C  C  G  T  C  T  T  T  T  C  C  T  ), 
Stra13 (T  A  C  A  A  G  C  T  G  G  T  G  A  T  T  T  G  T  C  G  G   and C  T  G  G  G  A  A  G  A  T  T  T  C  A  G  G  T  C-
C  C  G  ), and glyceraldehyde-3-phosphate dehydrogenase (A  G  G  A  G  C  G  A  G-
A  C  C  C  C  A  C  T  A  A  C  A  T   and G  T  G  A  A  G  A  C  A  C  C  A  G  T  A  G  A  C  T  C  C  A  C  G  ).
Northern blot analysis
20 μg of total RNA was run on formaldehyde-agarose gels and hybridized 
with 
32P-labeled cDNA probes for Stra13 and 36B4.
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